Organic Coatings Ltd

Organic Coatings Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Organic Coatings Ltd

₹ 18.8 4.96%
16 Jun 12:35 p.m.
organic-coatings.com BSE: 531157
About

Incorporated in 1965, Organic Coatings Ltd is mainly dealing with Inks and its auxiliaries.[1]

Key Points

Business Overview:[1][2]
OCL is engaged in the business of manufacturing and trading In Printing Inks
& allied products. The company sells its products across India and to other countries including North and South America, the CIS region, the Middle East, and Africa.

Website BSE
  • Market Cap ₹ 18.8 Cr.
  • Current Price ₹ 18.8
  • High / Low ₹ 30.4 / 13.1
  • Stock P/E
  • Book Value ₹ 0.02
  • Dividend Yield 0.00 %
  • ROCE -24.1 %
  • ROE -197 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company is expected to give good quarter

Cons

  • Stock is trading at 940 times its book value
  • Company has low interest coverage ratio.
  • Promoter holding is low: 6.06%
  • Company has a low return on equity of -109% over last 3 years.
  • Company might be capitalizing the interest cost
  • Debtor days have increased from 84.2 to 105 days.
  • Promoter holding has decreased over last 3 years: -49.8%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Commodities Chemicals Chemicals & Petrochemicals Specialty Chemicals

Edit Columns
Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
5.93 6.50 5.19 6.11 9.04 13.06 6.16 3.39 6.35 7.07 5.53 5.87 9.62
5.31 6.09 4.85 5.79 8.27 12.27 6.32 3.79 6.72 7.53 5.75 6.46 10.10
Operating Profit 0.62 0.41 0.34 0.32 0.77 0.79 -0.16 -0.40 -0.37 -0.46 -0.22 -0.59 -0.48
OPM % 10.46% 6.31% 6.55% 5.24% 8.52% 6.05% -2.60% -11.80% -5.83% -6.51% -3.98% -10.05% -4.99%
0.02 0.00 0.01 0.04 0.01 0.02 0.01 0.02 0.00 0.02 0.03 0.03 0.03
Interest 0.38 0.41 0.34 0.36 0.34 0.33 0.33 0.30 0.20 0.20 0.18 0.17 0.16
Depreciation 0.22 0.25 0.23 0.23 0.22 0.23 0.22 0.21 0.21 0.21 0.23 0.23 0.24
Profit before tax 0.04 -0.25 -0.22 -0.23 0.22 0.25 -0.70 -0.89 -0.78 -0.85 -0.60 -0.96 -0.85
Tax % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
0.04 -0.25 -0.22 -0.23 0.22 0.26 -0.70 -0.89 -0.78 -0.85 -0.60 -0.96 -0.85
EPS in Rs 0.05 -0.33 -0.29 -0.30 0.29 0.34 -0.91 -0.89 -0.78 -0.85 -0.60 -0.96 -0.85
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
45.57 40.69 29.94 37.10 35.59 27.54 14.05 22.07 22.90 26.83 28.96 28.09
44.77 39.35 27.65 35.20 34.40 25.99 13.56 21.61 21.54 24.99 29.09 29.84
Operating Profit 0.80 1.34 2.29 1.90 1.19 1.55 0.49 0.46 1.36 1.84 -0.13 -1.75
OPM % 1.76% 3.29% 7.65% 5.12% 3.34% 5.63% 3.49% 2.08% 5.94% 6.86% -0.45% -6.23%
1.42 0.27 0.32 0.55 0.24 0.40 0.05 0.11 0.16 0.07 0.05 0.11
Interest 1.94 1.42 1.17 1.06 1.12 1.18 1.39 1.47 1.49 1.45 1.16 0.71
Depreciation 1.41 1.40 1.31 1.35 1.34 1.29 1.30 1.07 0.98 0.93 0.86 0.91
Profit before tax -1.13 -1.21 0.13 0.04 -1.03 -0.52 -2.15 -1.97 -0.95 -0.47 -2.10 -3.26
Tax % 0.00% 0.00% 0.00% 25.00% 0.00% 0.00% 0.00% 1.52% 0.00% 0.00% 0.00% 0.00%
-1.12 -1.21 0.13 0.03 -1.03 -0.51 -2.15 -2.00 -0.95 -0.47 -2.10 -3.26
EPS in Rs -1.46 -1.58 0.17 0.04 -1.34 -0.66 -2.80 -2.61 -1.24 -0.61 -2.11 -3.27
Dividend Payout % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: -4%
5 Years: 15%
3 Years: 7%
TTM: -3%
Compounded Profit Growth
10 Years: %
5 Years: -14%
3 Years: %
TTM: -55%
Stock Price CAGR
10 Years: 8%
5 Years: 18%
3 Years: 36%
1 Year: 21%
Return on Equity
10 Years: -26%
5 Years: -79%
3 Years: -109%
Last Year: -197%

Balance Sheet

Figures in Rs. Crores

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 7.67 7.67 7.67 7.67 7.67 7.67 7.67 7.67 7.67 7.67 9.97 9.97
Reserves -0.21 -1.42 0.58 0.62 -0.43 -0.93 -3.06 -5.05 -5.99 -6.48 -6.68 -9.95
10.78 9.21 8.51 7.49 8.30 9.33 12.53 12.20 11.98 10.85 7.73 10.16
18.06 13.03 11.89 13.42 15.62 5.78 5.21 7.55 6.06 7.07 6.75 14.10
Total Liabilities 36.30 28.49 28.65 29.20 31.16 21.85 22.35 22.37 19.72 19.11 17.77 24.28
15.08 13.81 16.42 15.26 14.07 12.79 11.49 10.45 9.51 8.72 8.70 9.07
CWIP 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
21.22 14.68 12.23 13.94 17.09 9.06 10.86 11.92 10.21 10.39 9.07 15.21
Total Assets 36.30 28.49 28.65 29.20 31.16 21.85 22.35 22.37 19.72 19.11 17.77 24.28

Cash Flows

Figures in Rs. Crores

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
7.41 3.50 3.66 2.27 0.45 -0.75 -1.27 1.39 1.55 2.70 0.89 0.44
-0.28 -0.12 -1.94 -0.09 -0.02 0.06 0.00 0.01 -0.02 -0.12 -0.81 -1.25
-6.61 -3.37 -1.87 -2.07 -0.32 -0.14 1.86 -1.79 -1.72 -2.58 -0.03 1.72
Net Cash Flow 0.51 0.01 -0.15 0.11 0.12 -0.84 0.58 -0.39 -0.18 -0.01 0.05 0.91
Free Cash Flow 7.09 3.34 1.62 2.09 0.31 -0.75 -1.27 1.35 1.51 2.56 0.04 -0.84
CFO/OP 926% 261% 160% 119% 38% -48% -259% 302% 114% 147% -685% -25%

Ratios

Figures in Rs. Crores

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 94.27 61.36 65.71 66.51 86.46 54.60 142.10 115.11 98.66 86.79 61.13 104.60
Inventory Days 64.50 56.98 66.59 60.29 72.24 68.20 140.74 81.27 73.24 71.00 62.98 96.19
Days Payable 137.89 99.32 117.04 118.75 154.59 102.60 193.78 162.06 123.28 139.51 109.37 215.22
Cash Conversion Cycle 20.88 19.02 15.25 8.05 4.11 20.20 89.07 34.32 48.63 18.29 14.73 -14.43
Working Capital Days -28.43 -53.37 -59.25 -27.45 -17.33 -28.23 0.00 -22.16 -19.92 -27.48 -14.12 -78.22
ROCE % 3.74% 1.48% 7.95% 6.76% 0.51% 4.18% -4.58% -3.13% 3.86% 7.63% -8.15% -24.06%

Insights

In beta
Mar 2014 Mar 2015 Mar 2018 Mar 2024 Mar 2025
Actual Production - Bulk Drugs / Intermediates
Kgs

Log in to view insights

Please log in to see hidden values.

Login
Actual Production - Formulations (Liquids)
Litres
Actual Production - Formulations (Tablets/Capsules)
Nos. (Millions)
Installed Capacity - Bulk Drugs / Intermediates
Kgs
Installed Capacity - Formulations (Liquids)
Litres
Installed Capacity - Formulations (Tablets/Capsules)
Nos. (Millions)
Workforce (Permanent Employees)
Number
Material Consumption Rate (% of Revenue)
%

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
55.83% 55.83% 55.83% 55.83% 55.83% 55.83% 55.83% 38.00% 29.73% 22.54% 6.06% 6.06%
0.65% 0.65% 0.65% 0.65% 0.65% 0.65% 0.65% 0.50% 0.50% 0.50% 0.50% 0.50%
43.51% 43.52% 43.52% 43.52% 43.52% 43.51% 43.51% 61.51% 69.78% 76.96% 93.44% 93.45%
No. of Shareholders 2,4342,4112,4292,5442,5122,5902,7662,7792,7882,7942,7612,736

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings